Provided by Tiger Trade Technology Pte. Ltd.

Alzamend Neuro, Inc

1.72
+0.02001.18%
Post-market: 1.720.00000.00%19:59 EDT
Volume:393.65K
Turnover:674.70K
Market Cap:8.24M
PE:-0.65
High:1.76
Open:1.67
Low:1.59
Close:1.70
52wk High:2.68
52wk Low:0.8400
Shares:4.79M
Float Shares:4.78M
Volume Ratio:7.52
T/O Rate:8.24%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6287
EPS(LYR):-11.3245
ROE:-163.23%
ROA:-76.44%
PB:1.42
PE(LYR):-0.15

Loading ...

Jun 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 11, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 10, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 09, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 07, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 07, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 07, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 03, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jun 03, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 28, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 28, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 27, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 25, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 10, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 10, 2021

Correspondence

CORRESP [Cover] - Correspondence